Mca-PLGL-Dpa-AR-NH2

Mca-PLGL-Dpa-AR-NH2 incorporates an Mca fluorophore and Dpa quencher flanking a protease-sensitive PLGL sequence. Cleavage separates donor and quencher, leading to fluorescence enhancement. Researchers employ the construct to quantify matrix metalloproteinase activity. Applications include real-time protease imaging in vitro, inhibitor screening, and kinetic-mechanism analysis.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Mca-PLGL-Dpa-AR-NH2(CAS 1135689-33-6)

CAT No: R2547

CAS No:1135689-33-6

Synonyms/Alias:Mca-PLGL-Dpa-AR-NH2;1135689-33-6;HY-P3474;DA-55275;PD076947;CS-0611315;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C43H66N12O11
M.W/Mr.
927.1
Sequence
One Letter Code:PLGLXAR

Mca-PLGL-Dpa-AR-NH2 is a synthetic peptide substrate featuring a 7-methoxycoumarin-4-acetyl (Mca) fluorescent group and a 3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl (Dpa) quenching group, flanking a specific amino acid sequence. Engineered for high sensitivity in enzymatic assays, this fluorogenic peptide is widely recognized for its utility in monitoring protease activity, particularly matrix metalloproteinases (MMPs) and related enzyme families. Its design enables precise detection of substrate cleavage events, making it a valuable tool in biochemical research focused on proteolytic mechanisms, enzyme kinetics, and inhibitor screening.

Protease activity assays: The peptide serves as a robust substrate in real-time fluorescence-based assays for detecting and quantifying the activity of proteases such as MMPs, ADAMs, and other endopeptidases. Upon enzymatic cleavage at the PLGL sequence, disruption of the FRET pair results in increased fluorescence emission, providing a direct, quantitative measure of proteolytic activity. This mechanism is instrumental in characterizing enzyme specificity, determining kinetic parameters, and evaluating the impact of various modulators on protease function.

Enzyme inhibitor screening: In drug discovery and biochemical research, Mca-PLGL-Dpa-AR-NH2 enables high-throughput screening of small molecule or peptide-based inhibitors targeting proteolytic enzymes. By monitoring changes in fluorescence in the presence of candidate compounds, researchers can efficiently identify and characterize inhibitors, assess their potency, and elucidate mechanisms of action. This application supports the development of selective inhibitors and the study of structure-activity relationships within protease families.

Biochemical pathway elucidation: Utilization of this fluorogenic substrate in cell-free or cell-based systems allows investigation of protease-mediated processes within complex biological samples. The peptide's sensitivity facilitates the detection of endogenous or recombinant enzyme activities, supporting research into extracellular matrix remodeling, signal transduction, and other proteolysis-dependent pathways. Such studies contribute to a deeper understanding of physiological and pathological processes involving proteolytic regulation.

Analytical method development: The unique optical properties of the Mca/Dpa FRET pair make the peptide a preferred standard in the optimization and validation of analytical protocols for protease quantification. Its defined cleavage site and reproducible fluorescence response enable the establishment of reliable assay conditions, calibration curves, and performance benchmarks for various detection platforms, including microplate readers and automated screening systems.

Enzyme kinetics and mechanistic studies: The peptide's design is ideally suited for detailed kinetic analyses of protease catalysis. Researchers can employ it to determine parameters such as Km, Vmax, and catalytic efficiency, as well as to probe substrate specificity and cleavage site preferences. These insights are essential for dissecting enzyme mechanisms, comparing isoform activities, and guiding the rational engineering of proteases with tailored properties for research or industrial applications.

InChI
InChI=1S/C43H66N12O11/c1-22(2)15-29(53-42(64)32-10-8-14-55(32)35(57)17-25-18-36(58)66-33-19-26(65-6)11-12-27(25)33)39(61)49-21-34(56)51-30(16-23(3)4)40(62)54-31(20-44)41(63)50-24(5)38(60)52-28(37(45)59)9-7-13-48-43(46)47/h11-12,18-19,22-24,28-32H,7-10,13-17,20-21,44H2,1-6H3,(H2,45,59)(H,49,61)(H,50,63)(H,51,56)(H,52,60)(H,53,64)(H,54,62)(H4,46,47,48)/t24-,28-,29-,30-,31-,32-/m0/s1
InChI Key
GNGRCYXAOSUGRN-KNIQQNQGSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicePeptide Analysis ServicesPeptide Modification ServicescGMP Peptide ServicePeptide Synthesis ServicesPeptide CDMOPeptide Nucleic Acids SynthesisEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers